Vasopeptidase-activated latent ligands of the histamine receptor-1

International Immunopharmacology

Volumn 17, Issue 3, 2013, Pages 677-683

  Gera, Lajos ^a   Roy, Caroline ^b   Charest Morin, Xavier ^b   Marceau, François ^b  

^a UNIVERSITY OF COLORADO   (United States)

^b LAVAL UNIVERSITY   (Canada)

Author keywords

Aminopeptidase N; Angiotensin converting enzyme; Bradykinin B2 receptor; Histamine H1 receptor; Human umbilical vein; Prodrug

Indexed keywords

AMASTATIN; BRADYKININ B2 RECEPTOR; CETIRIZINE; DIPEPTIDYL CARBOXYPEPTIDASE; HISTAMINE DERIVATIVE; HISTAMINE H1 RECEPTOR; L ALANYL HISTAMINE; MEPYRAMINE; MICROSOMAL AMINOPEPTIDASE; OMAPATRILAT; PEPTIDASE; UNCLASSIFIED DRUG; VASOPEPTIDASE;

ANIMAL CELL; ARTICLE; BINDING ASSAY; BINDING COMPETITION; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; DRUG BINDING; DRUG POTENCY; DRUG RELEASE; DRUG STRUCTURE; ENDOCYTOSIS; ENZYME ACTIVATION; EXPRESSION VECTOR; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; METABOLIC ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIORECEPTOR ASSAY; UMBILICAL VEIN; VASCULAR SMOOTH MUSCLE; VENOCONSTRICTION;

AMINOPEPTIDASE N; ANGIOTENSIN CONVERTING ENZYME; BRADYKININ B(2) RECEPTOR; HISTAMINE H(1) RECEPTOR; HUMAN UMBILICAL VEIN; PRODRUG;

ANIMALS; ARRESTINS; BRADYKININ; CETIRIZINE; CHO CELLS; CRICETULUS; HEK293 CELLS; HISTAMINE; HISTAMINE ANTAGONISTS; HUMANS; LIGANDS; PEPTIDE HYDROLASES; PEPTIDES; PRODRUGS; PYRILAMINE; RADIOLIGAND ASSAY; RECEPTOR, BRADYKININ B2; RECEPTORS, HISTAMINE H1; UMBILICAL VEINS; VASOCONSTRICTION;

EID: 84884273948     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2013.08.014     Document Type: Article

References (26)

1. T.A. Hoover, M. Lippmann, E. Grouzmann, F. Marceau, and P. Herscu Angiotensin converting enzyme inhibitor induced angioedema: a review of the pathophysiology and risk factors Clin Exp Allergy 40 2010 50 61
2. L. Gera, C. Roy, M.T. Bawolak, J. Bouthillier, A. Adam, and F. Marceau Met-Lys-bradykinin-Ser-Ser, a peptide produced by the neutrophil from kininogen, is metabolically activated by angiotensin converting enzyme in vascular tissue Pharmacol Res 64 2011 528 534
3. 9-kallidin-induced vasoconstrictor responses by metallopeptidase inhibition in isolated human umbilical artery J Pharmacol Exp Ther 313 2005 1355 1360
4. 1 receptor antagonism J Pharmacol Exp Ther 317 2006 300 308
5. L.M. Leeb-Lundberg, F. Marceau, W. Müller-Esterl, D.J. Pettibone, and B.L. Zuraw International union of pharmacology. XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol Rev 57 2005 27 77
6. 2 receptors Br J Pharmacol 158 2009 1375 1386
7. 2 receptor stimulated with the amphibian peptide maximakinin: insight into the endosomal inactivation of kinins Pharmacol Res 65 2012 247 253
8. 2 receptor-mediated agonist endocytosis and trafficking and angiotensin-converting enzyme J Pharmacol Exp Ther 337 2011 33 41
9. L. Gera, C. Roy, M.T. Bawolak, X. Charest-Morin, and F. Marceau N-terminal extended conjugates of the agonists and antagonists of both bradykinin receptor subtypes: structure-activity relationship, cell imaging using ligands conjugated with fluorophores and prospect for functionally active cargoes Peptides 34 2012 433 446
10. R.M. Fryer, J. Segreti, P.N. Banfor, D.L. Widomski, B.J. Backes, and C.W. Lin Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema Br J Pharmacol 153 2008 947 955
11. 194 Mol Pharmacol 61 2002 391 399
12. U. Lendeckel, T. Wex, D. Reinhold, T. Kähne, K. Frank, and J. Faust Induction of the membrane alanyl aminopeptidase gene and surface expression in human T-cells by mitogenic activation Biochem J 319 1996 817 821
13. B.M. Altura, D. Malaviya, C.F. Reich, and L.R. Orkin Effects of vasoactive agents on isolated human umbilical arteries and veins Am J Physiol 222 1972 345 355
14. F. Marceau, D. deBlois, E. Petitclerc, L. Levesque, G. Drapeau, and R. Audet Vascular smooth muscle contractility assays for inflammatory and immunological mediators Int Immunopharmacol 10 2010 1344 1353
15. G.A. Koumbadinga, M.T. Bawolak, E. Marceau, A. Adam, L. Gera, and F. Marceau A ligand-based approach to investigate the expression and function of angiotensin converting enzyme in intact human umbilical vein endothelial cells Peptides 31 2010 1546 1554
16. K. Fukasawa, H. Fujii, Y. Saitoh, K. Koizumi, Y. Aozuka, and K. Sekine Aminopeptidase N (APN/CD13) is selectively expressed in vascular endothelial cells and plays multiple roles in angiogenesis Cancer Lett 243 2006 135 143
17. P. Di Matteo, G.L. Arrigoni, L. Alberici, A. Corti, C. Gallo-Stampino, and C. Traversari Enhanced expression of CD13 in vessels of inflammatory and neoplastic tissues J Histochem Cytochem 59 2011 47 59
18. C.T. Supuran, and A. Scozzafava Carbonic anhydrase activators: amino acyl/dipeptidyl histamine derivatives bind with high affinity to Izozymes I, II and IV and act as efficient activators Bioorg Med Chem 7 1999 2915 2923
19. 2 receptor antagonist Immunopharmacology 43 1999 187 194
20. M.T. Bawolak, L. Gera, G. Morissette, J.M. Stewart, and F. Marceau B-9972 (D-Arg-[Hyp3, Igl5, Oic7, Igl8]-bradykinin) is an inactivation-resistant agonist of the bradykinin B2 receptor derived from the peptide antagonist B-9430 (D-Arg-[Hyp3, Igl5, D-Igl7, Oic8]-bradykinin): pharmacologic profile and effective induction of receptor degradation J Pharmacol Exp Ther 323 2007 534 546
21. M. Sibony, D. Segretain, and J.M. Gasc Angiotensin-converting enzyme in murine testis: step-specific expression of the germinal isoform during spermiogenesis Biol Reprod 50 1994 1015 1026
22. G. Morissette, E. Petitclerc, and F. Marceau Loss of function of vascular smooth muscle cells by nitric oxide-dependent and -independent interactions with tumorigenic cells Int J Cancer 112 2004 830 839
23. C.M. Munoz, and L.M. Leeb-Lundberg Receptor-mediated internalization of bradykinin. DDT1 MF-2 smooth muscle cells process internalized bradykinin via multiple degradative pathways J Biol Chem 267 1992 303 309
24. F. Jardinaud, G. Banisadr, F. Noble, S. Mélik-Parsadaniantz, H. Chen, and C. Dugave Ontogenic and adult whole body distribution of aminopeptidase N in rat investigated by in vivo autoradiography Biochimie 86 2004 105 113
25. L. Alberici, L. Roth, K.N. Sugahara, L. Agemy, V.R. Kotamraju, and T. Teesalu De novo design of a tumor-penetrating peptide Cancer Res 73 2013 804 812
26. C. Schmitt, M. Voegelin, A. Marin, M. Schmitt, F. Schegg, and P. Hénon Selective aminopeptidase-N (CD13) inhibitors with relevance to cancer chemotherapy Bioorg Med Chem 21 2013 2135 2144